Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace

Forlini, Cynthia; Lipworth, Wendy; Carter, Adrian; Kerridge, Ian

doi:10.1080/21507740.2019.1665128

Cited by 4 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Numerous publications related to stem cells highlighted their reliance on limited [ 48 , 73 ] or “ambiguous” evidence [ 84 ]. Other criticisms focused on experimental techniques in neurotechnology [ 55 , 85 – 87 ] and digital health tools, which may not be rigorously tested [ 47 ] or have strong supporting evidence [ 8 , 41 , 45 ]. Articles critiqued the quality of DTC lab tests [ 30 , 31 ] as well as the lack of clinical evidence and consensus supporting their widespread use [ 74 , 81 , 88 ].…”

Section: Resultsmentioning

confidence: 99%

“…Some questioned whether purveyors of DTC healthcare should be held to medicolegal standards of informed consent [ 92 ]. Others noted that with consumer health apps, individuals often proceed through the informed consent by clicking through without carefully reading the text-laden forms [ 67 , 79 ], raising concerns about individuals’ awareness of the data being collected [ 8 , 66 , 87 , 93 ]. Similar concerns about terms of service agreements were raised with tele-mental health services [ 78 ].…”

Section: Resultsmentioning

confidence: 99%

“…Additional ethical concerns at the societal level included the medicalization of normal states leading to overdiagnosis [ 87 ], blurred boundaries between treatment and lifestyle [ 18 , 87 ], and the role of algorithmic bias in exacerbating health disparities [ 47 , 59 , 83 ].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Ethical issues in direct-to-consumer healthcare: A scoping review

Nagappan,

Kalokairinou,

Wexler

2024

PLOS Digit Health

View full text Add to dashboard Cite

An increasing number of health products and services are being offered on a direct-to-consumer (DTC) basis. To date, however, scholarship on DTC healthcare products and services has largely proceeded in a domain-specific fashion, with discussions of relevant ethical challenges occurring within specific medical specialties. The present study therefore aimed to provide a scoping review of ethical issues raised in the academic literature across types of DTC healthcare products and services. A systematic search for relevant publications between 2011–2021 was conducted on PubMed and Google Scholar using iteratively developed search terms. The final sample included 86 publications that discussed ethical issues related to DTC healthcare products and services. All publications were coded for ethical issues mentioned, primary DTC product or service discussed, type of study, year of publication, and geographical context. We found that the types of DTC healthcare products and services mentioned in our sample spanned six categories: neurotechnology (34%), testing (20%), in-person services (17%), digital health tools (14%), telemedicine (13%), and physical interventions (2%). Ethical arguments in favor of DTC healthcare included improved access (e.g., financial, geographical; 31%), increased autonomy (29%), and enhanced convenience (16%). Commonly raised ethical concerns included insufficient regulation (72%), questionable efficacy and quality (70%), safety and physical harms (66%), misleading advertising claims (56%), and privacy (34%). Other frequently occurring ethical concerns pertained to financial costs, targeting vulnerable groups, informed consent, and potential burdens on healthcare providers, the healthcare system, and society. Our findings offer insights into the cross-cutting ethical issues associated with DTC healthcare and underscore the need for increased interdisciplinary communication to address the challenges they raise.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Ethical issues in direct-to-consumer healthcare: A scoping review

Nagappan,

Kalokairinou,

Wexler

2024

PLOS Digit Health

View full text Add to dashboard Cite

show abstract

“…Adentrar no mercado de trabalho para custear o curso de pós-graduação é uma opção para esses novos pesquisadores, alternativa na qual seu conhecimento científico pode ser considerado atrativo para empresa e ser vinculado a um produto (Forlini, et al 2019). A indústria de neurociências, em especial a de neuromodulação, é uma opção de campo de atuação no mercado de trabalho, que está em ampla expansão e em busca de candidatos que tenham um perfil profissional inovador, disponível para aprender e produzir (Cota, et al 2020).…”

Section: A Inserção Do Estudante De Neuroengenharia E Neurociências N...unclassified

Desenvolvimento de novas tecnologias da neuromodulação como alternativa para aperfeiçoamento e inserção no mercado de trabalho

Filho

Mesquita²,

Medeiros³

2022

RSD

View full text Add to dashboard Cite

A neuromodulação está presente na vida de muitos pacientes que utilizam dispositivos como marcapasso cardíaco, implante inibidor de dor crônica, implante coclear, e até estimuladores cerebrais para aumento de performance de atletas, gamers e estudantes. Questões políticas e econômicas que geraram cortes em bolsas e investimento nos programas de pós-graduação dificultam manter a produção científica em alto nível no Brasil. O mercado global de produtos para neurotecnologia movimenta bilhões de dólares e tende a crescer US $13,3 bilhões até 2022. Esta pesquisa visa identificar, na indústria da Neuromodulação, oportunidades de atuação profissional para estudantes de pós-graduação, como uma opção de autofinanciamento e perspectiva de campo de trabalho. Para tanto, foram utilizadas 44 referências de língua inglesa e portuguesa, em sua maioria datadas entre 2010 até 2020. As pesquisas em neurotecnologia tendem a aumentar depois da criação, em 2012, do Projeto Cérebro Humano. Os distúrbios neurológicos acometem parcela significativa da população mundial, com tendência a aumentar nos próximos anos, tornando este mercado lucrativo e com boas projeções futuras. A pesquisa em Neuromodulação é um produto comercializável e existem empresas no mercado com interesse em financiar o desenvolvimento de novos produtos e tecnologias, proporcionando aos estudantes das áreas de Neuroengenharia e Neurociências oportunidade de inserção ao mercado antes mesmo de concluir sua formação.

show abstract

Preface: Ethical aspects of DIY and commercial neurotechnologies

Bárd¹,

Hildt²

2020

Ethical Dimensions of Commercial and DIY Neurotechnologies

View full text Add to dashboard Cite

Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace

Cited by 4 publications

References 9 publications

Ethical issues in direct-to-consumer healthcare: A scoping review

Ethical issues in direct-to-consumer healthcare: A scoping review

Desenvolvimento de novas tecnologias da neuromodulação como alternativa para aperfeiçoamento e inserção no mercado de trabalho

Preface: Ethical aspects of DIY and commercial neurotechnologies

Contact Info

Product

Resources

About